Long-term exposure to pollutants was linked to higher psoriasis risk, especially in people with genetic predispositions.

An expert discusses how ITP treatment success is monitored through maintaining safe platelet levels and symptom control, ...

Emilie Aschenbrenner, PharmD, BCOP, discusses how integrating CD38-targeted therapies into first-line treatment for transplant-ineligible multiple myeloma requires balancing clinical benefit, cost, ...

High stigma due to HIV was also associated with depression and drug use, making the reduction in stigma vital for improving the care of women with HIV.

Jason Bergsbaken, PharmD, MBA, BCOP, explains the value of pharmacist involvement in precision molecular tumor boards and end-of-life care discussions, highlighting their role in ensuring ...

Hair and scalp disorders in patients with skin of color are frequently misdiagnosed, often due to educational gaps and ...

More than 8 in 10 patients with rheumatoid arthritis were taking 5 or more medications at once, a practice linked to older ...

DYNE-251 received FDA breakthrough therapy designation, showcasing its potential for patients with Duchenne muscular ...

Individuals who used smokeless tobacco and e-cigarettes had an increased risk of developing age-related macular degeneration ...

Physicians were more likely to include terms that undermine the competence and sincerity of Black patients' claims when ...

Proposed Affordable Care Act (ACA) premium hikes threaten health care access, with potential increases of over 75% for ...

Elise S. Tremblay, MD, MPH, explores potential policy solutions and research directions to address ongoing challenges in insulin affordability and access.